MedTrace Logo

Study of NMB (Company's Name) Drug Ejecting Balloon for Arteriovenous Fistulae

NCT01538108 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-02-23

No results posted yet for this study

Summary

The purpose of this study is to demonstrate the safety and effectiveness of the use of NMB's percutaneous transluminal angioplasty (PTA) Balloon.

Conditions

  • Obstructive Lesions of Arteriovenous Dialysis Fistulae

Interventions

DEVICE

PTA Balloon catheter with paclitaxel

patients treated by the NMB's PTA Balloon catheter with paclitaxel

PROCEDURE

Plain Balloon angioplasty (PBA)

PBA

Sponsors & Collaborators

  • N.M.B. Medical Applications Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538108 on ClinicalTrials.gov